Relates to coverage for treatments to slow the progression of Alzheimer's disease and related dementias

This bill requires health insurance plans, including individual, group, and government-sponsored coverage, to pay for FDA-approved treatments and diagnostic tests for Alzheimer's disease and related dementias. The coverage applies when a licensed physician determines the treatment is medically necessary and follows FDA labeling requirements. Plans subject to this bill cannot use step therapy, which would otherwise require patients to try less expensive options before accessing these specific treatments. The law takes effect on January 1st following its passage and applies to all policies issued, renewed, or modified on or after that date.